The Good Cancer Plus Companion Journal

This 2-in-1 Edition includes The Good Cancer Book PLUS Companion Journal.In her breakout book, The Good Cancer, Dr. Marla Friedman revealed her life's journey with cancer. Each chapter provided stories of survival and healing along with easy to implement tips compiled and organized into this companion journal. When you buy this book, you'll find pages organized and ready for you to journal through every part of the process from the initial diagnosis to preparing for surgery. There are also pages for keeping track of medication, second opinions, diagnoses; as well as, favorite recipes, exercises, meal prep etc. For more than 16 years, Dr. Friedman has been educating cancer patients about taking control of their own healing process. She founded the South Florida Thyroid Cancer Survivor's Association (ThyCa) after she was diagnosed and couldn't find a support group specific to her own cancer. In 2015 Marla was diagnosed with cancer yet again. A diagnosis of breast cancer was shocking and led to surgeries and treatment. Dr. Marla Friedman is a full-time professor of business and entrepreneurship. She is a best-selling Amazon author and national speaker on cancer topics. Marla is a founding member of Lighthouse Dragons SOS, a dragon boat team for breast cancer survivors based in Jupiter, FL.

Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity’s Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization. Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.

The Routledge Companion to Philosophy of Medicine is a comprehensive guide to topics in the fields of epistemology and metaphysics of medicine. It examines traditional topics such as the concept of disease, causality in medicine, the epistemology of the randomized controlled trial, the biopsychosocial model, explanation, clinical judgment and phenomenology of medicine and emerging topics, such as philosophy of epidemiology, measuring harms, the concept of disability, nursing perspectives, race and gender, the metaphysics of Chinese medicine, and narrative medicine. Each of the 48 chapters is written especially for this volume and with a student audience in mind. For pedagogy and clarity, each chapter contains an extended example illustrating the ideas discussed. This text is intended for use as a reference for students in courses in philosophy of medicine and philosophy of science, and pairs well with The Routledge Companion to Bioethics for use in medical humanities and social science courses.

For a decade The Breast Reconstruction Guidebook has been the best resource on this topic for women who have had a mastectomy. Equal parts science and support, it is filled with stories that illustrate the emotional and physical components of breast reconstruction. Readers will find advice about choosing a doctor and a procedure, insurance and payment issues, how to prepare for surgery, and what to expect during recovery. Expert commentary by physicians and insights from patients inform this book, as does the exhaustive research by the author, a two-time breast cancer survivor who has twice had reconstructive surgery. New in this edition are discussions of• the pros and cons of saline and silicone implants • solutions for post-lumpectomy cosmetic problems• new immediate-delayed reconstruction when post-mastectomy radiation may be required• the benefits and limitations of nipple-sparing mastectomy• considerations for direct-to-implant reconstruction• newly developed tissue flap procedures • who can best apply nipple and areola tattoos and why tattoos may not last• enriching fat with stem cells so it stays in the breast• patient-controlled tissue expansion • how insurance and health care reform affect reconstruction -- Brice W. McKane, M.D., F.A.C.S., Texas Center for Breast Reconstruction

Stereotactic body radiation therapy (SBRT) has emerged as an important innovative treatment for various primary and metastatic cancers. This book provides a comprehensive and up-to-date account of the physical/technological, biological, and clinical aspects of SBRT. It will serve as a detailed resource for this rapidly developing treatment modality. The organ sites covered include lung, liver, spine, pancreas, prostate, adrenal, head and neck, and female reproductive tract. Retrospective studies and prospective clinical trials on SBRT for various organ sites from around the world are examined, and toxicities and normal tissue constraints are discussed. This book features unique insights from world-renowned experts in SBRT from North America, Asia, and Europe. It will be necessary reading for radiation oncologists, radiation oncology residents and fellows, medical physicists, medical physics residents, medical oncologists, surgical oncologists, and cancer scientists.

It started with the discovery of a little bump on the side of her neck at a birthday luncheon. It turned into two years of back-to-back cancers, the harshest chemo, a stem cell transplant, a mastectomy and reconstruction. In this book, Laren Rusch Watson, a Board Certified Holistic Health and Nutrition Coach shares the emotional rollercoaster that she went through first with the shock of her diagnosis and then with reconciling the necessary chemical cocktail with her organic, all natural belief system; she shares it all in her typical casual style as if you were having coffee. The second part of the book she aims to help cancer patients through the difficult time just after diagnosis and through treatment by organizing all that she learned into seven sections, from food and health information to life altering lessons, to trippy spiritual experiences. This book will support the newly diagnosed cancer patient in finding strength and optimism through the hardest time of their life.